Research ArticleBasic Sciences
A Fluorinated Glucose Analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic Tracer for Rapid Tumor Detection
P. Som, H. L. Atkins, D. Bandoypadhyay, J. S. Fowler, R. R. MacGregor, K. Matsui, Z. H. Oster, D. F. Sacker, C. Y. Shiue, H. Turner, C-N. Wan, A. P. Wolf and S. V. Zabinski
Journal of Nuclear Medicine July 1980, 21 (7) 670-675;
P. Som
H. L. Atkins
D. Bandoypadhyay
J. S. Fowler
R. R. MacGregor
K. Matsui
Z. H. Oster
D. F. Sacker
C. Y. Shiue
H. Turner
C-N. Wan
A. P. Wolf


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
A Fluorinated Glucose Analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic Tracer for Rapid Tumor Detection
P. Som, H. L. Atkins, D. Bandoypadhyay, J. S. Fowler, R. R. MacGregor, K. Matsui, Z. H. Oster, D. F. Sacker, C. Y. Shiue, H. Turner, C-N. Wan, A. P. Wolf, S. V. Zabinski
Journal of Nuclear Medicine Jul 1980, 21 (7) 670-675;
A Fluorinated Glucose Analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic Tracer for Rapid Tumor Detection
P. Som, H. L. Atkins, D. Bandoypadhyay, J. S. Fowler, R. R. MacGregor, K. Matsui, Z. H. Oster, D. F. Sacker, C. Y. Shiue, H. Turner, C-N. Wan, A. P. Wolf, S. V. Zabinski
Journal of Nuclear Medicine Jul 1980, 21 (7) 670-675;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Cancer Metabolism Historical Perspectives: A Chronicle of Controversies and Consensus
- Genetic evidence that uptake of the fluorescent analog 2NBDG occurs independently of known glucose transporters
- At Last, 18F-FDG for Inflammation and Infection!
- A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers
- Cypate and Cypate-Glucosamine as Near-Infrared Fluorescent Probes for In Vivo Tumor Imaging
- Metabolic plasticity meets gene regulation
- Hexokinase 2 Is Targetable for HK1-Negative, HK2-Positive Tumors from a Wide Variety of Tissues of Origin
- Modeling cancer metabolism on a genome scale
- Defining Key Signaling Nodes and Therapeutic Biomarkers in NF1-Mutant Cancers
- Optimum Lean Body Formulation for Correction of Standardized Uptake Value in PET Imaging
- Reduced 64Cu Uptake and Tumor Growth Inhibition by Knockdown of Human Copper Transporter 1 in Xenograft Mouse Model of Prostate Cancer
- In Vitro and In Vivo Characterization of 2-Deoxy-2-18F-Fluoro-D-Mannose as a Tumor-Imaging Agent for PET
- Development of a Colon Cancer GEMM-Derived Orthotopic Transplant Model for Drug Discovery and Validation
- Prospective Study of 2-[18F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group Study
- Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands
- Evidence-Based Approach to the Introduction of Positron Emission Tomography in Ontario, Canada
- One Step Closer to Imaging Vulnerable Plaque in the Coronary Arteries
- Patterns of FDG uptake in post-thoracotomy surgical scars in patients with lung cancer
- The radiation burden of radiological investigations
- Synthesis and Biologic Evaluation of 64Cu-Labeled Rhenium-Cyclized {alpha}-MSH Peptide Analog Using a Cross-Bridged Cyclam Chelator
- 99mTc- and 111In-Labeled {alpha}-Melanocyte-Stimulating Hormone Peptides as Imaging Probes for Primary and Pulmonary Metastatic Melanoma Detection
- Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer
- Advances in paediatric tumour imaging
- 3'-18F-Fluoro-3'-Deoxy-L-Thymidine: A New Tracer for Staging Metastatic Melanoma?
- Prospective Comparison of 18F-FDG PET with Conventional Imaging Modalities (MRI, CT, and 67Ga Scintigraphy) in Assessment of Combined Intraarterial Chemotherapy and Radiotherapy for Head and Neck Carcinoma
- Metabolic Fate of 18F-FDG in Mice Bearing Either SCCVII Squamous Cell Carcinoma or C3H Mammary Carcinoma
- FDG Metabolism: Quaecumque Sunt Vera ...
- 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer
- Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin's Lymphoma
- Evaluation of the Early Effect of Local Irradiation on Normal Rodent Bone Marrow Metabolism Using FDG: Preclinical PET Studies
- Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations
- Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer